INTERVIEW: Philips bullish about new HealthTech direction

Philips Healthcare had a tough 2014, with lackluster financial results leading to the departure of CEO Deborah DiSanzo in July. However, the firm’s decision to merge its healthcare and consumer lifestyle products units into a new HealthTech division is a positive move, Gene Saragnese, CEO of its Imaging Business Groups, told Clinica

Philips Healthcare had a tough 2014, with lackluster financial results leading to the departure of CEO Deborah DiSanzo in July. However, the firm’s decision to merge its healthcare and consumer lifestyle products units into a new HealthTech division is a positive move, Gene Saragnese, CEO of its Imaging Business Groups, told Clinica

“Philips has made a very bold bet as the world changes around us,” believes Gene Saragnese, CEO of the company’s...

More from Archive

More from Medtech Insight

Waters’ Purchase Of BD Biosciences & Dx Brings Growth Potential Alongside Trade-Offs

 
• By 

Waters Corp. will acquire Becton Dickinson’s Biosciences and Diagnostics business for $17.5bn, doubling its TAM to $40B. Analysts praise the flow cytometry addition but see weaker growth in diagnostics.

European MedTech Keeps Calm Despite US Threats Of 30% Tariffs

 

MedTech Europe wants the EU to continue its commitment to reach a negotiated tariff solution with the US and measured restraint amid escalating trade tensions.

Medtech Will Benefit From Boost To EU’s Quantum Technology Initiative

 

The European Commission is focusing on how tiny particles behave to help create an EU industrial “powerhouse.”